Načítá se...
NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
Atrial fibrillation is a heart arrhythmia associated with increased risk for ischemic stroke. Vitamin K antagonists were developed to decrease a patient's clotting risk; however, these medications require therapeutic monitoring and have several drug interactions. Novel oral anticoagulants (NOAC...
Uloženo v:
| Vydáno v: | Cureus |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cureus
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572042/ https://ncbi.nlm.nih.gov/pubmed/28845374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1395 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|